Rab 6A inhibitors are a class of compounds designed to target and modulate the activity of the Rab 6A protein, a member of the Rab family of small GTPases. Rab proteins are key regulators of vesicular trafficking, controlling the movement of vesicles between different cellular compartments. Rab 6A, in particular, plays a crucial role in mediating the transport of vesicles between the Golgi apparatus and the endoplasmic reticulum (ER), as well as in the sorting of cargo destined for other cellular locations. It ensures that proteins and lipids are correctly packaged and transported along the secretory and endocytic pathways. Inhibitors of Rab 6A function by interfering with its ability to bind and hydrolyze GTP, a process necessary for its role in vesicle trafficking. This inhibition can disrupt the normal movement of vesicles and affect cellular homeostasis.
The inhibition of Rab 6A can have widespread effects on intracellular trafficking and the proper localization of proteins and membranes. By targeting Rab 6A, these inhibitors block its function in organizing and directing vesicle transport, leading to disruptions in the flow of cargo between the ER, Golgi, and other cellular compartments. This can result in altered protein sorting, mislocalization of enzymes, and potential buildup of vesicles within the cytoplasm. Rab 6A inhibitors are important tools for studying the detailed mechanisms of vesicle transport and understanding how small GTPases like Rab 6A control the dynamics of intracellular trafficking. These inhibitors help researchers explore how changes in vesicular transport impact processes such as secretion, endocytosis, and organelle maintenance, providing insights into the complex regulatory networks that maintain cellular organization.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts ARF-dependent coat assembly by inhibiting GDP-GTP exchange, indirectly affecting Rab6A's associated pathways by disrupting Golgi apparatus function and vesicle trafficking. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
An ionophore that disrupts Golgi function, altering vesicle trafficking and could impede Rab6A-mediated transport indirectly. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Destabilizes microtubules, potentially affecting vesicle transport and distribution where Rab6A is involved. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Binds to tubulin, leading to microtubule depolymerization and impacting Rab6A-related vesicle transport indirectly. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules, which could alter normal Rab6A-related vesicle transport by preventing necessary microtubule dynamics. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Inhibits microtubule formation, potentially affecting Rab6A's role in vesicle trafficking by altering microtubule-dependent transport. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Disrupts actin filaments, which could indirectly influence Rab6A-mediated vesicle movement as actin dynamics are crucial for certain transport events. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Inhibits dynamin, affecting clathrin-mediated endocytosis and potentially impacting Rab6A's role in vesicle trafficking indirectly. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
A non-competitive inhibitor of Cdc42, which is involved in actin polymerization; although indirect, it can modulate vesicle transport processes where Rab6A operates. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Blocker of clathrin-mediated endocytosis, may indirectly affect Rab6A by disrupting vesicle formation and trafficking pathways. | ||||||